6 results

• Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations

  October 29, 2025

  Irvin Jackson

  Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns.

• Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit

  October 17, 2025

  Irvin Jackson

  Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.

• Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis

  October 2, 2025

  Irvin Jackson

  A Dupixent lawsuit blames the atopic dermatitis drug for causing a woman to develop a deadly form of cancer, which caused her death.

• Libtayo SJS/TEN Lawsuit Filed Over Fatal Reaction To Skin Cancer Drug

  October 11, 2023

  Irvin Jackson

  A Libtayo SJS/TEN lawsuit blames the skin cancer drug's lack of label warnings for the painful death of a California wife and mother.

• Generic Remeron Recall Issued Over Labeling Error Which Could Result In Overdose

  January 6, 2020

  Irvin Jackson

  A generic Regeneron recall warns that some bottles contain pills with twice the dose due to a labeling error.

• Praluent, Repatha Costs Outweigh Health Benefits: Study

  September 14, 2015

  Irvin Jackson

  A new report warns that the cholesterol drugs Praluent and Repatha may be too expensive for the modest benefits they give to patients.